RE:HUGE NEWS?They are going to be starting from ground zero on a proff of concept research project. They need to get a partner that has at least started clinical trials if they hope to have revenues within the next two years on the pharma side of things. They call themselves a pharma company but right now they are just a grow op. They have zero pharma capabilites at the moment and do not have a single potential pharma application that is even in early stage clinical trials.
They shoudl have closed the deal with TRPX, which has been making big jumps the last three days on way above average volumes. I think TRPX may be close to a deal with anohter compnay based on teh recent activity over there.